In a recent study published in the journal Nutrients, researchers at Seoul National University of Science and Technology conducted a meta-analysis to investigate the pros and cons of brown seaweed consumption (BSC) as a management intervention against diabetes. They collated and analyzed 23 prior publications on the topic and found that BSC is an effective … Read more
5.2% of the global population carry hemoglobin abnormalities, resulting in 300,000 to 400,000 children born with severe hemoglobinopathies annually. Thalassemia, a hereditary hemoglobinopathy, occurs in 4.4 out of every 10,000 live births, and is prevalent in Mediterranean coastal areas, Africa, the Middle East, Southeast Asia, and southern China. To facilitate greater understanding of thalassemia, a … Read more
In a recent review published in the journal Diabetes Therapy, researchers weighed the evidence regarding ketogenic diets and their efficacy for the treatment of type 1 diabetes (T1D), type 2 diabetes (T2D), and gestational diabetes (GD). Their findings indicate that many questions on this subject remain unresolved and that many further investigations are needed before … Read more
In a recent study published in JAMA Network Open, researchers develop and test the effectiveness of a Virtual Diabetes Specialty Clinic (VDiSC), a virtual model facilitating comprehensive diabetes care remotely. VDiSC integrates and supports continuous glucose monitoring (CGM) for self-management of diabetes. This platform also provides behavioral health support for diabetes-related complications and helps evaluate decision-support … Read more
New research has uncovered elevated rates of high blood sugar, or hyperglycemia, among patients with breast cancer who are treated with the oral medication alpelisib. The results are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society. Alpelisib targets the phosphoinositide 3-kinase (PI3K) protein that is involved in cell growth and when … Read more
In a recent study published in the journal eClinical Medicine, researchers performed a meta-analysis to evaluate the glucose-lowering potential of glucagon-like peptide-1 receptor agonist (GLP-1 RA)-based therapies among diabetes mellitus type 2 (T2D) patients. Novel GLP-1-RAs, including tirzepatide, individually or combined with insulin fixed-ratio combinations (FRCs) or sodium-glucose cotransporter-2 inhibitors (SGLT-2i), as well as high-dosage … Read more